Since it has become more and more evident in recent years that so-called “isolated” PAX6 aniridia can also frequently have systemic concomitant diseases (hormonal, gastrointestinal, metabolic, cerebral), the term “aniridia syndrome” or “PAX6 syndrome” has been recommended1, 3. This evidence concerns the gene PAX6 and syndromic aniridia.